Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corinna Weber-Schoendorfer

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Reproductive Toxicology (Elmsford, N.Y.)|June 24, 2008
The safety of cetirizine during pregnancy. A prospective observational cohort studyCorinna Weber-Schoendorfer, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)|January 26, 2016
Pregnancy outcome after tocilizumab therapy in early pregnancy-a case series from the German Embryotox Pharmacovigilance CenterCorinna Weber-Schoendorfer, Christof Schaefer
Seminars in Perinatology|March 27, 2025
When pregnancy termination fails: A tale of two teratogens: methotrexate and misoprostol - A narrative mini-reviewOrna Diav-Citrin, Corinna Weber-Schoendorfer
Archives of Gynecology and Obstetrics|May 16, 2009
Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in PregnancyChristof Schaefer, Reinhard Meister, Corinna Weber-Schoendorfer
Reproductive Toxicology (Elmsford, N.Y.)|May 16, 2009
Fetal outcome after technetium scintigraphy in early pregnancyChristof Schaefer, Reinhard Meister, René Wentzeck, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|December 11, 2012
[Drug safety in pregnancy - the Embryotox project]Christof Schaefer, Marc Oppermann, Evelin Wacker, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 1, 2008
Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerationsChristof Schaefer, Asher Ornoy, Maurizio Clementi, et al.
British Journal of Clinical Pharmacology|July 24, 2012
Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new featureMarc Oppermann, Stephanie Padberg, Angela Kayser, et al.
Rheumatology (Oxford, England)|December 27, 2013
No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort studyCorinna Weber-Schoendorfer, Maria Hoeltzenbein, Evelin Wacker, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 19, 2018
Pregnancy outcome after first-trimester exposure to metformin: A prospective cohort studyStephan Scherneck, Natalie Schlinke, Evelin Beck, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Reproductive Toxicology (Elmsford, N.Y.)|June 24, 2008
The safety of cetirizine during pregnancy. A prospective observational cohort studyCorinna Weber-Schoendorfer, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)|January 26, 2016
Pregnancy outcome after tocilizumab therapy in early pregnancy-a case series from the German Embryotox Pharmacovigilance CenterCorinna Weber-Schoendorfer, Christof Schaefer
Seminars in Perinatology|March 27, 2025
When pregnancy termination fails: A tale of two teratogens: methotrexate and misoprostol - A narrative mini-reviewOrna Diav-Citrin, Corinna Weber-Schoendorfer
Archives of Gynecology and Obstetrics|May 16, 2009
Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in PregnancyChristof Schaefer, Reinhard Meister, Corinna Weber-Schoendorfer
Reproductive Toxicology (Elmsford, N.Y.)|May 16, 2009
Fetal outcome after technetium scintigraphy in early pregnancyChristof Schaefer, Reinhard Meister, René Wentzeck, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|December 11, 2012
[Drug safety in pregnancy - the Embryotox project]Christof Schaefer, Marc Oppermann, Evelin Wacker, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 1, 2008
Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerationsChristof Schaefer, Asher Ornoy, Maurizio Clementi, et al.
British Journal of Clinical Pharmacology|July 24, 2012
Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new featureMarc Oppermann, Stephanie Padberg, Angela Kayser, et al.
Rheumatology (Oxford, England)|December 27, 2013
No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort studyCorinna Weber-Schoendorfer, Maria Hoeltzenbein, Evelin Wacker, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 19, 2018
Pregnancy outcome after first-trimester exposure to metformin: A prospective cohort studyStephan Scherneck, Natalie Schlinke, Evelin Beck, et al.
Pageof 4